{
    "code": "02013181",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02013181",
    "time": "2016-11-18 18:33:33",
    "許可證字號": "衛署藥輸字第013181號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "107\/12\/18",
    "發證日期": "73\/12\/18",
    "許可證種類": "原料藥",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "null",
    "中文品名": "&quot;普佛馬可&quot; 布馬平粉劑",
    "英文品名": "BROMAZEPAM &quot;PROFARMACO&quot;",
    "適應症": "寧神劑",
    "劑型": "040（粉）",
    "包裝": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "01製劑原料",
    "主成分略述": [
        ""
    ],
    "限制項目": "02輸　入 34第四級管制藥品",
    "申請商名稱": "0801701100  東信化學藥品有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F250107000  CAMBREX PROFARMACO MILANO S.R.L.",
        "製造廠廠址": "PAULLO (MI), VIA CURIEL 34, ITALY",
        "製造廠公司地址": "PAULLO (MI), VIA CURIEL 34, ITALY",
        "": ""
    },
    "CCC號列": "29333300009 阿華吩坦尼（ＩＮＮ）、安尼勒立汀（ＩＮＮ）、培集屈密特（ＩＮＮ）、溴西泮（ＩＮＮ）、狄芬諾新（ＩＮＮ）、狄芬諾西萊（ＩＮＮ）、狄匹潘濃（ＩＮＮ）、吩坦尼（ＩＮＮ）、酚派丙酮（ＩＮＮ）、派醋甲酯（ＩＮＮ）、潘他唑新（ＩＮＮ）、配西汀（ＩＮＮ）、配西汀（ＩＮＮ）中間體、苯環利定（ＩＮＮ）（ＰＣＰ）、吩諾配立汀（ＩＮＮ）、派苯甲醇（ＩＮＮ）、匹立屈密特（ＩＮＮ）、普魯匹蘭（ＩＮＮ）及屈美配立汀（ＩＮＮ）；其鹽類Alfentanil (INN), anileridine (INN), bezitramide (INN), bromazepam (INN), difenoxin (INN), diphenoxylate (INN), dipipanone (INN), fentanyl (INN), ketobemidone (INN), methylphenidate (INN), pentazocine (INN), pethidine (INN), pethidine (INN) intermediate a",
    "藥理治療分類": "",
    "ingredients": []
}